Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2010

01-01-2010 | Clinical Research

Reduction in Plasma Levels of Inflammatory and Oxidative Stress Indicators After Roux-En-Y Gastric Bypass

Authors: Edilson João Cabrera, Antonio Carlos Valezi, Vinicius Daher Alvares Delfino, Edson Lopes Lavado, Decio Sabbatini Barbosa

Published in: Obesity Surgery | Issue 1/2010

Login to get access

Abstract

Background

Obesity is considered to be associated with high levels of oxidative stress and inflammation. Anticipated weight loss secondary to bariatric surgery may offer an opportunity to evaluate this association. We studied a few markers of oxidative stress and inflammation in 20 obese patients submitted to Roux-en-Y gastric bypass (RYGBP).

Methods

Variations in plasma levels of indicators of oxidative stress (malondialdehyde (MDA), superoxide dismutase (SOD), catalase, glutathione (GSH), glutathione disulfide (GSSG), and total radical antioxidant parameter (TRAP)) and inflammation (α1-acid glycoprotein (AGP) and C-reactive protein (CRP)), as well as variations in plasma levels of leptin, glucose, glycated hemoglobin (HbA1c), and insulin were investigated in the preoperative period and 12 months postsurgery in 20 class III obese individuals submitted to bariatric surgery (obese group) and 20 non-obese individuals (control group).

Results

Twelve months postsurgery, there was a significant reduction (p < 0.01) in median values of BMI (46.75/30.17 kg/m2) and in plasma levels of MDA (16.70/9.11 nmol/g prot), SOD (10.70/9.24 U/mgHb), GSSG (210.80/148.20 mM/g of Hb), AGP (125.70/75.80 mg/dL), CRP (1.31/0.38 mg/dL), and leptin (15.04/3.58 ng/mL). A significant drop (p < 0.05) in plasma levels of HbA1c (5.81/4.98%) was also observed. On the other hand, a significant increase in plasma levels of GSH (2.002/2.823 mM/g of Hb) and TRAP (585.40/815.48 μM Trolox®), p < 0.01, and in catalase plasma levels (12.06/13.22 Δt/mgHb/min), p < 0.05, was seen. No statistically significant variations in glucose (96.3/84.8 mg/dL) or insulin plasma levels (9.91/7.88 U/mL) occurred. Calculated homeostasis model assessment index did not statistically change 12 months postsurgery (2.36/1.66).

Conclusions

In the preoperative period, the obese group individuals showed higher oxidation and inflammation levels and lower indices of antioxidant defense than those of the control group. One year after RYGBP, an improvement in antioxidant protection, associated with a reduction in inflammatory and oxidative markers, was observed, indicating that these individuals presented a lower degree of oxidative stress.
Literature
1.
2.
Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002;10(suppl.2):97S–104S.CrossRefPubMed
3.
4.
5.
Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–56.CrossRefPubMed
6.
7.
Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792–800.CrossRefPubMed
8.
9.
Matthews DR, et al. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7): 412–19.
10.
Jentzsch MA, Bachmann H, Furst P. 1996 Improved analysis of malondialdehide in human body fluids. Free Radic Biol Med. 1996;20:251–6.CrossRefPubMed
11.
Repetto M, et al. Oxidative stress in blood of HIV infected patients. Clin Chim Acta. 1996;29(255):107–17.CrossRef
12.
Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27(3):502–22.CrossRefPubMed
13.
Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3):469–74.CrossRefPubMed
14.
15.
Cummings DE, Overduin J, Schubert KEF. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89(6):2608–15.CrossRefPubMed
16.
Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia. 2004;47(3):581–9.CrossRefPubMed
17.
Scopinaro N, et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. Obes Surg. 2007;17(2):185–92.CrossRefPubMed
18.
Geloneze B, Tambascia M. Avaliação Laboratorial e Diagnóstico da Resistência insulínica. Arq Bras Endocrinol Metab. 2006;50(2):208–15.
19.
Oliveira EP, Souza MLA, Lima MDA. Índice HOMA (homeostasis model assessment) na Prática Clínica: Uma Revisão. J Bras Patol Med Lab. 2005;41(4):237–43.CrossRef
20.
Polizogopoulou EV, et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52:1098–103.CrossRef
21.
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236(5):554–9.CrossRefPubMed
22.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30(suppl 1):S42–7.CrossRef
23.
Mohamed-Ali V, et al. β-Adrenergic regulation of IL-6 release from adipose tissue. In vivo and in vitro. J Clin Endocrinol Metab. 2001;86(12):5864–69.CrossRefPubMed
24.
Prasad K. C-Reactive protein increases oxygen radical generation by neutrophils. J Cardiovasc Pharmacol Therapeut. 2004;9(3):209–9.
25.
Kopp HP, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042–47.CrossRefPubMed
26.
Selvin E, et al. The effect of weight loss on C-reactive protein. Arch Intern Med. 2007;167:31–9.CrossRefPubMed
27.
Fournier T, Medjoubi NN, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta Amsterdan. 2000;1482(1/2):157–71.
28.
29.
Matarese G, Moschos S, Mantzoros C. Leptin in immunology. J Immunol. 2005;173:3137–42.
30.
Singh P, et al. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2007;27:e302–7.CrossRefPubMed
31.
Boulomié A. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999;13:1231–38.
32.
Furukawa S, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–61.PubMed
33.
Ribeiro SMR, et al. A formação e os efeitos das espécies reativas de oxigênio no meio biológico. Biosc J. 2005;21(3):133–49.
34.
Del Rio D, Stewart AJ, Pelllegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15:316–28.CrossRefPubMed
35.
Dandona P, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab. 2001;86(1):355–62.CrossRefPubMed
36.
Uzun H, et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg. 2004;14:659–65.CrossRefPubMed
37.
Dougall WC, Nick HS. Manganese superoxide dismutase: a hepatic acute phase protein regulated by interleukin-6 and glucocorticoids. Endocrinology. 1991;129:2376–84.CrossRefPubMed
38.
Sigfrid LA, et al. Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells. J Mol Endoc. 2003;31:509–18.CrossRef
39.
Ashfaq S, et al. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol. 2006;47:1005–11.CrossRefPubMed
40.
Ghiselli A, et al. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med. 2000;29(11):1106–14.CrossRefPubMed
41.
Vanucchi H, et al. Papel dos nutrientes na peroxidação lipídica e no sistema de defesa anti-oxidante. Medicina. 1998;31:31–44.
42.
Carlini MP. Avaliação Nutricional e de Qualidade de Vida de Pacientes Submetidos à Cirurgia Bariátrica. 2001. Dissertação de Mestrado (Mestrado em Engenharia De Produção)—Universidade Federal De Santa Catarina. Florianópolis.
Metadata
Title
Reduction in Plasma Levels of Inflammatory and Oxidative Stress Indicators After Roux-En-Y Gastric Bypass
Authors
Edilson João Cabrera
Antonio Carlos Valezi
Vinicius Daher Alvares Delfino
Edson Lopes Lavado
Decio Sabbatini Barbosa
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 1/2010
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-9988-2

Other articles of this Issue 1/2010

Obesity Surgery 1/2010 Go to the issue

Letter to the Editor

Succinylcholine: The Dilemma with the Evidence

Letter to the Editor

Preoperative Weight Loss in the Context of a Comprehensive Lifestyle Intervention

Case Report

Bariatric Surgery in the Management of Childhood Obesity: Should There be an Age Limit?

Clinical Report

Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy

Clinical Research

Non-transectional Open Gastric Bypass as the Definitive Bariatric Procedure for 61 Patients with BMI of 70 and Higher

Clinical Research

Variation of Outcome in Weight Loss with Band Volume Adjustments under Clinical and Radiological Control Following Laparoscopic Adjustable Gastric Banding